Literature DB >> 16010288

The binding activity of yeast RNAs to yeast Hek2p and mammalian hnRNP K proteins, determined using the three-hybrid system.

Agnieszka Paziewska1, Lucjan S Wyrwicz, Jerzy Ostrowski.   

Abstract

K homology (KH) domains are scaffolds for the binding of RNAs by the heterogeneous nuclear ribonucleoprotein (hnRNP) K protein and its yeast ortholog, Hek2p. KH domains are remarkably conserved between mammals and yeast. To assess the binding activity for yeast RNA of the two proteins, we used full-length K protein and Hek2p as baits in the yeast three-hybrid system. All the unique RNA sequences bound by Hek2p and all but two bound by K protein represented different fragments of only two transcripts, encoded by the 18S and 25S ribosomal RNA genes. Most of them were transcribed from the antisense strand. The RNA-binding activity of K protein was significantly higher than that of Hek2p. These results and those from our previously published reports demonstrate that the specificity of target RNA recognition by both the K protein and Hek2p depends on both RNA-specific sequences and the structure of the protein. Both mammalian K protein and its yeast ortholog may be involved in the regulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010288

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  6 in total

1.  Distinct roles for Khd1p in the localization and expression of bud-localized mRNAs in yeast.

Authors:  Yuko Hasegawa; Kenji Irie; André P Gerber
Journal:  RNA       Date:  2008-09-19       Impact factor: 4.942

2.  The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation.

Authors:  Fushi Wen; Renyuan Zhou; Alex Shen; Andrew Choi; Diana Uribe; Jiaqi Shi
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

Review 3.  Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.

Authors:  Zeinab Safarpour Lima; Mostafa Ghadamzadeh; Farzad Tahmasebi Arashloo; Ghazaleh Amjad; Mohammad Reza Ebadi; Ladan Younesi
Journal:  J Hematol Oncol       Date:  2019-04-11       Impact factor: 17.388

Review 4.  RNA-Binding Proteins in Acute Leukemias.

Authors:  Konstantin Schuschel; Matthias Helwig; Stefan Hüttelmaier; Dirk Heckl; Jan-Henning Klusmann; Jessica I Hoell
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

Review 5.  The translational factor eIF3f: the ambivalent eIF3 subunit.

Authors:  Roberta Marchione; Serge A Leibovitch; Jean-Luc Lenormand
Journal:  Cell Mol Life Sci       Date:  2013-01-25       Impact factor: 9.261

Review 6.  The interactome: predicting the protein-protein interactions in cells.

Authors:  Dariusz Plewczyński; Krzysztof Ginalski
Journal:  Cell Mol Biol Lett       Date:  2008-10-06       Impact factor: 5.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.